Related Experiment Video
Updated: May 5, 2026

Computerized Dynamic Posturography for Postural Control Assessment in Patients with Intermittent Claudication
Published on: December 11, 2013
Editor's Choice - A Core Outcome Set for Patients with Chronic Symptomatic Peripheral Arterial Disease
Sabrina L M Zwetsloot1, Lotte Rijken2, Igor Koncar3
1Department of Surgery, Amsterdam UMC, location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands; Amsterdam Cardiovascular Sciences, Atherosclerosis & Aortic Diseases, Amsterdam, The Netherlands.
A core outcome set (COS) was developed for chronic symptomatic peripheral arterial disease (PAD) patients. This standardized list of 11 outcomes will improve clinical and AI research for PAD.
Area of Science:
- Cardiology
- Medical Informatics
- Clinical Research Methodology
Background:
- Peripheral arterial disease (PAD) research suffers from heterogeneous outcomes and selective reporting.
- Standardized outcome reporting is crucial for clinical research and the development of artificial intelligence (AI) predictive models.
- The VASCUL-AID project aims to create AI models for cardiovascular disease progression in PAD patients.
Purpose of the Study:
- To establish a Core Outcome Set (COS) for patients with chronic symptomatic PAD.
- To ensure research outcomes reflect the needs of all stakeholders, including patients.
- To standardize outcome reporting in both clinical and AI research for PAD.
Main Methods:
- The study followed Core Outcome Measures in Effectiveness Trials (COMET) recommendations.
- A longlist of outcomes was generated from a systematic literature review and patient/healthcare professional (HCP) focus groups.
- A Delphi study involving 153 HCPs and 92 patients, followed by an expert consensus meeting, finalized the COS.
Main Results:
- The initial longlist contained 67 outcomes.
- The Delphi study achieved an 85% participation rate.
- The final COS includes 11 essential outcomes: death, myocardial infarction, major amputation, acute limb ischaemia, thromboembolic complications, disease progression, pain-free walking distance, physical activity, health-related quality of life, smoking cessation, and good communication by healthcare providers.
Conclusions:
- This is the first COS specifically developed for patients with chronic symptomatic PAD.
- The COS is recommended for adoption in clinical trials and AI research involving PAD.
- Standardizing outcomes will enhance the quality and comparability of PAD research.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management

